10x Genomics Class A financial statements
10X 지노믹스NASDAQ:TXG · Nasdaq · Healthcare$93.50+5.34%
2026-10-02 close10x Genomics Class A's published financial data is dated 2026-10-04. 2024 revenue was $611M. 2024 operating profit was −$195M.
Reported results
Quantus Signal · live data · not investment advice · Privacy Policy